Website Page

Dear Colleagues and Friends,

The IASLC 2024 Hot Topic in Basic and Translational Science Meeting: Tolerance and Resistance to Targeted Therapy in Non-Small Cell Lung Cancer (HTTR 2024) is set to take place December 13-15, 2024 at the Hilton Washington DC National Mall The Wharf. We invite you to join us at this dynamic meeting.

IASLC’s Hot Topic Meetings in Basic and Translational Science serve as a platform to share cutting-edge research, discuss challenges in the field, and explore collaborative opportunities among academic and with industrial researchers to advance the understanding and treatment of non-small cell lung cancer. The expected audience includes basic scientists, translational researchers, oncologists, pathologists, molecular biologists, radiologists, pharmaceutical and biotech professionals, academic researchers, students, and more. The multidisciplinary nature of the audience reflects the comprehensive approach required to address the complexities of tolerance and resistance to targeted therapy in non-small cell lung cancer. The meeting aims to foster collaboration and knowledge exchange among professionals with complementary expertise to advance the understanding and treatment of NSCLC.

We look forward to seeing you in Washington, DC in December 2024.

HTTR 2024 Conference Co-Chairs

Alice Berger, PhD

William Lockwood, PhD

Montse Sanchez-Cespedes, PhD

Kenichi Suda, MD, PhD

Stay Connected


© 2024 International Association for the Study of Lung Cancer - IASLC HTTR 2024